ATCC Wins Multimillion Dollar Contract to Manage and Operate One of the World’s Largest Repositories of Biological Specimens
Program adds to ATCC’s growing portfolio of biorepository management services
Manassas, VA, United StatesOctober 11, 2016
Leidos Biomedical Research, Inc. (Leidos Biomed) awarded ATCC, a global leader in biological materials management and standards, a two-year base option subcontract to manage and operate one of the largest repositories of biological specimens in the world, in Frederick, Md. The subcontract is valued up to $32 million over a seven-year period if all options are executed. This award will be fully funded under the Leidos Biomed prime contract HHSN261200800001E with the National Cancer Institute, National Institutes of Health.
Under this subcontract, ATCC will receive, store, and distribute biospecimens to basic and clinical investigators supporting cancer and infectious disease research, as well as manage operational logistics and costs.
“ATCC is a world-recognized biological resource center with over 90 years of successful biorepository expertise,” said Dr. Raymond H. Cypess, ATCC Chairman and CEO. “We are honored to support Leidos Biomed and the National Cancer Institute in their important mission of supporting the biomedical community with advancements in cancer and infectious disease research. This program extends ATCC’s clinical biorepository management portfolio for both government and commercial customers.”
The NCI at Frederick Central Repository is part of the Frederick National Laboratory for Cancer Research, a federal national laboratory sponsored by NCI and operated under contract by Leidos Biomed.
The NCI at Frederick Central Repository is one of the largest repositories in the world with an inventory of more than 15 million clinical specimens. It serves as a national resource for the biomedical community by providing biospecimen collection management to the NCI and other government organizations.
ATCC is a premier global biological materials and information resource and standards organization and the leading developer and supplier of authenticated cells lines and microorganisms. With a history of scientific advancements spanning nearly a century, ATCC offers an unmatched combination of being the world’s largest and most diverse collection of biological research solutions and a mission-driven, trusted partner that supports and encourages scientific collaboration. ATCC products, services, and people provide the scientific community with credible biological products, advanced model systems, and custom solutions that support complex research in a variety of innovative applications resulting in incredible achievements in basic science, drug discovery, translational medicine, and public health. ATCC is a nonprofit organization with headquarters in Manassas, VA, and an R&D innovation center in Gaithersburg, MD.
Contact: Kim Testa, senior director, Corporate Communications & Public Affairs, ATCC, 703-365-2700 ext. 2753